pyrrolidonecarboxylic acid and Multiple Sclerosis

pyrrolidonecarboxylic acid has been researched along with Multiple Sclerosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hyun, JS; Jeong, IH; Kim, HH; Kim, HJ; Kong, BS; Park, SJ1
Gwirtsman, H; Hershman, JM; Pekary, AE; Smith, VP; Tourtellotte, WW1

Other Studies

2 other study(ies) available for pyrrolidonecarboxylic acid and Multiple Sclerosis

ArticleYear
Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance.
    PloS one, 2017, Volume: 12, Issue:7

    Topics: Acetates; Acetone; Adolescent; Adult; Aged; Child; Citric Acid; Female; Formates; Glucose; Humans; Hydroxybutyrates; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Metabolome; Metabolomics; Middle Aged; Multiple Sclerosis; Multivariate Analysis; Neuromyelitis Optica; Proton Magnetic Resonance Spectroscopy; Pyrrolidonecarboxylic Acid; Young Adult

2017
High levels of thyrotropin-releasing hormone precursor peptide immunoreactivity and binding substance occur in human cerebrospinal fluid.
    Neuroendocrinology, 1991, Volume: 53, Issue:3

    Topics: Alzheimer Disease; Amino Acid Sequence; Chromatography, High Pressure Liquid; Humans; Molecular Sequence Data; Multiple Sclerosis; Protein Precursors; Pyrrolidonecarboxylic Acid; Thyrotropin-Releasing Hormone

1991